See more : Cipher Mining Inc. (CIFRW) Income Statement Analysis – Financial Results
Complete financial analysis of Bullfrog AI Holdings, Inc. Common Stock (BFRG) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Bullfrog AI Holdings, Inc. Common Stock, a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
- Zuari Industries Limited (ZUARIIND.NS) Income Statement Analysis – Financial Results
- Haoxiangni Health Food Co.,Ltd. (002582.SZ) Income Statement Analysis – Financial Results
- Reve Technologies, Inc. (BSSP) Income Statement Analysis – Financial Results
- Seed Capital Solutions Plc (SCSP.L) Income Statement Analysis – Financial Results
- Fram Skandinavien AB (FRAM-B.ST) Income Statement Analysis – Financial Results
Bullfrog AI Holdings, Inc. Common Stock (BFRG)
Industry: Medical - Healthcare Information Services
Sector: Healthcare
Website: https://www.bullfrogai.com
About Bullfrog AI Holdings, Inc. Common Stock
BullFrog AI Holdings, Inc., through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. It offers bfLEAP, an AI/ML platform for the analysis of preclinical and/or clinical data. The company also has licensing agreements with George Washington University for rights to use siRNA targeting Beta2-spectrin in the treatment of human diseases, including hepatocellular carcinoma, obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis; and Johns Hopkins University for the use of a formulation of Mebendazole for the treatment of human cancer or neoplastic disease. BullFrog AI Holdings, Inc. was founded in 2017 and is based in Gaithersburg, Maryland.
| Metric | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Revenue | 65.00K | 10.00K | 0.00 | 0.00 |
| Cost of Revenue | 5.20K | 800.00 | 0.00 | 0.00 |
| Gross Profit | 59.80K | 9.20K | 0.00 | 0.00 |
| Gross Profit Ratio | 92.00% | 92.00% | 0.00% | 0.00% |
| Research & Development | 1.43M | 609.27K | 0.00 | 0.00 |
| General & Administrative | 3.99M | 1.86M | 555.36K | 347.19K |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 3.99M | 1.86M | 555.36K | 347.19K |
| Other Expenses | 0.00 | 459.00 | 0.00 | 0.00 |
| Operating Expenses | 5.43M | 2.47M | 555.36K | 347.19K |
| Cost & Expenses | 5.43M | 2.47M | 555.36K | 347.19K |
| Interest Income | 183.70K | 459.00 | 0.00 | 0.00 |
| Interest Expense | 79.09K | 347.15K | 40.40K | 11.77K |
| Depreciation & Amortization | 1.73K | 1.05K | 236.56K | 206.30K |
| EBITDA | -5.28M | -2.45M | -555.36K | -347.19K |
| EBITDA Ratio | -8,115.47% | -24,542.97% | 0.00% | 0.00% |
| Operating Income | -5.37M | -2.46M | -555.36K | -347.19K |
| Operating Income Ratio | -8,257.73% | -24,558.01% | 0.00% | 0.00% |
| Total Other Income/Expenses | 11.66K | -346.69K | -30.48K | 5.50K |
| Income Before Tax | -5.36M | -2.80M | -585.84K | -341.69K |
| Income Before Tax Ratio | -8,239.80% | -28,024.87% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | 347.60K | -196.16K | -194.53K |
| Net Income | -5.36M | -2.80M | -585.84K | -341.69K |
| Net Income Ratio | -8,239.80% | -28,024.87% | 0.00% | 0.00% |
| EPS | -0.89 | -0.46 | -0.10 | -0.06 |
| EPS Diluted | -0.89 | -0.46 | -0.10 | -0.06 |
| Weighted Avg Shares Out | 6.05M | 6.09M | 5.65M | 5.65M |
| Weighted Avg Shares Out (Dil) | 6.05M | 6.09M | 5.65M | 5.65M |
BullFrog AI to Present at Webull LIVE! Healthcare Webinar on January 17
BullFrog AI Issues Letter to Shareholders
BullFrog AI Launches Preclinical Study to Investigate BF-114's Potential in Battling Obesity
ASP Isotopes and Bullfrog AI Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV
BullFrog AI to Present at Benzinga All Access Event on October 20
BullFrog AI Announces Identification of Novel Potential Drug Targets for Colorectal Cancer Using Its AI-Driven bfLEAP™ Platform
BullFrog AI Founder and CEO Vin Singh to Present Company Overview at BioFuture 2023
BullFrog AI Announces Launch of BullFrog Data Networks™, a Data Insights Tool Powered by the bfLEAP™ Platform
BullFrog AI Founder and CEO Vin Singh to Present Company Overview at Maxim Group's Emerging Growth in AI Virtual Tech Conference Series
BullFrog AI Announces Three-Year Global Strategic Partnership with the Lieber Institute for Brain Development
Source: https://incomestatements.info
Category: Stock Reports